Pancras C. Wong

Identification of angiotensin II receptor subtypes

Andrew T. Chiu, William F. Herblin, Dale E. McCall et al. · Biochemical and Biophysical Research Communications · 1989 · 822 citations

Life Sciences, Biochemistry, Pharmacology +12

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

Nirmala Raghavan, Charles Frost, Zhigang Yu et al. · Drug Metabolism and Disposition · 2008 · 604 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>c</i>]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa

Donald Pinto, Michael J. Orwat, Stephanie C. Koch et al. · Journal of Medicinal Chemistry · 2007 · 397 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

Pancras C. Wong, William A. Price, Andrew T. Chiu et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 330 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

Andrew T. Chiu, Dale E. McCall, William A. Price et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 317 citations

Medicine, Medicinal Chemistry, Pharmacology +13